To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Japanese researchers succeed in making generations of mouse clones
11-03-2013
Using the technique that created Dolly the sheep, researchers from the RIKEN Center for Developmental Biology in Kobe, Japan have identified a way to produce healthy mouse clones that live a normal lifespan and can be sequentially cloned indefinitely. In an experiment that started in 2005, ...
A new future for an old crop: barley enters the genomics age
30-01-2013
The barley genome is almost twice the size of that of humans and determining the sequence of its DNA has proved to be a major challenge. This paper published in Nature is a detailed overview of the functional portions of the barley genome, revealing the order and structure of its 26,000 ...
NovAliX enters into fragment-based drug discovery alliance with Kyowa Hakko Kirin
17-01-2013
NovAliX SAS announced that it has entered into a fragment-based drug discovery alliance with Kyowa Hakko Kirin Co., Ltd., Japan. Within the alliance, the companies will collaborate to develop novel drug candidates against protein-protein interaction targets. Under the terms of the agreement ...
Evotec achieves milestone in drug discovery collaboration with Ono
15-01-2013
Evotec AG announced that a compound identified and optimised in a research collaboration with Ono Pharmaceutical Co., Ltd. has been nominated to enter pre-clinical development, leading to the payment of an agreed milestone. This collaboration project was initiated in March 2008. Evotec ...
The guide to biomolecular movie-making
08-01-2013
High-speed atomic force microscopy (HS-AFM) is providing the means to produce dramatic footage of moving biomolecules, and scientists at Kanazawa University leading the field. Toshio Ando and co-workers at Kanazawa University have developed and used HS-AFM to increase our understanding of ...
Neupro approved in Japan for Parkinson’s disease and Restless Legs Syndrome
07-01-2013
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Neupro® (rotigotine transdermal patch) for the treatment of Parkinson’s disease (PD) and for the symptomatic treatment of moderate-to-severe idiopathic Restless Legs Syndrome (RLS) in adults. In 2002 Otsuka Pharmaceutical ...
Astellas and UCB announce approval of Cimzia in Japan for the treatment of rheumatoid arthritis
04-01-2013
Astellas Pharma Inc. and UCB S.A. announced that UCB Japan has received marketing approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for Cimzia® (certolizumab pegol). Cimzia®, under joint development in Japan, has been approved as a 200 mg syringe for subcutaneous ...
Targeting drugs with hydrogels
06-11-2012
Researchers in Japan have developed a technique which allows them to control and target drug delivery to specific sites of the body at specific times, thus reducing side effects and improving treatment dramatically. The results were published in Science and Technology of Advanced ...
Tokyo Institute of Technology research: Towards medical treatments using cell level control
06-11-2012
Researchers at Tokyo Institute of Technology and the Weizmann Institute of Science identify a means of controlling biological processes that could help treatments for immune disease, neurological disorders and cancer.The cellular response to a number of signals including inflammatory ...
Takeda to Acquire LigoCyte Pharmaceuticals, Inc.
Gains First-in-Class Norovirus Vaccine Candidate and Virus-Like Particle Platform, Advancing Takeda's Commitment to Vaccines and Global Public Health
10-10-2012
Takeda Pharmaceutical Company Limited and LigoCyte Pharmaceuticals, Inc. jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and LigoCyte Pharmaceuticals, Inc. have entered into a definitive agreement for Takeda to acquire LigoCyte for an upfront payment of ...
Netmeeting
